Key facts
- It has raised $400K; the latest was Seed Round ($400K) in Mar 2026.
- Notable investors include KunzA.I Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Bionaute (Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for Bionaute (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bionaute (Biotechnology)
Developer of RNAi-based biopesticides intended to enable sustainable crop protection. The company designs AI-driven RNA molecules that silence essential genes in pests and pathogens, leveraging natural plant defense mechanisms to create residue-free, ecosystem-safe solutions, enabling farmers to protect crops from insects, fungi, viruses, and weeds while supporting environmentally responsible agriculture.
- Sector
- Materials and Resources
- HQ
- Santiago, Chile
- Founded
- 2023
- Employees
- 5
- Website
- bionaute.io/
- Ownership
- Privately Held (backing)
Bionaute (Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bionaute (Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bionaute (Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.